Skip to main content

The Pathophysiological Functions Mediated by D1 Dopamine Receptors

  • Chapter
Neurobiology of Central D1-Dopamine Receptors

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 204))

Abstract

Pharmacological and biochemical studies have established the presence of at least two types of central dopamine (DA) receptors. The D1 DA receptors are positively linked to the DA sensitive adenylate cyclase system, whereas the D2 DA receptors are probably negatively linked. The D2 DA receptors have been generally recognized as mediating the action of antipsychotic drugs as well as a variety of behaviors such as rotation and stereotypy. However, until recently, the D1 DA receptor was regarded as a receptor whose function is unknown and awaiting future discovery. The availability of selective D1 DA agonists (e.g. SKF 38393) and of D1 DA antagonists (e.g. SCH 23390) has made it possible to determine some behavioral effects which are associated with D1 or with both D1 and D2 DA receptors. In this presentation we will describe some behavioral responses which might be mediated by D1 and/or by both D1 and D2 DA receptors, and we will discuss their clinical relevance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. C. Ezrin-Waters and P. Seeman, 1977, Tolerance to haloperidol catalepsy, Eur. J. Pharmaco1., 41:321–327.

    Article  CAS  Google Scholar 

  2. E. Meller, J.Y. Lew, S. Kuga and M. Goldstein, 1984, The interaction of SCH 23390 with normosensitive (N) and supersensitive (S) dopamine receptors, The Pharamcologist, 26:163.

    Google Scholar 

  3. E. Meller, S. Kuga, A.J. Friedhoff and M. Goldstein, 1985, Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist, Life Sci., 36:1857–1864.

    Article  PubMed  CAS  Google Scholar 

  4. E. Meller, K. Bohmaker, M. Goldstein and A.J. Friedhoff, 1985, Inactivation of D1 and Do dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo, J. Pharmacol. Exp. Ther., 233:656–662.

    PubMed  CAS  Google Scholar 

  5. M. Goldstein, A.H. Battista, T. Ohmoto, B. Anagnoste and K. Fuxe, 1973, Tremor and involuntary movements in monkeys: Effect of L-dopa and of a dopamine receptor stimulating agent, Science, 179:816–817.

    CAS  Google Scholar 

  6. M. Goldstein and S. Kuga, 1984, Dopamine (DA) agonist induced compulsive biting (CB) behavior in monkeys: Animal model for Lesch-Nyhan syndrome, Soc. Neurosci., 10:239.1.

    Google Scholar 

  7. M. Goldstein, S. Kuga, N. Kusano, E. Meller, J. Dancis and R. Schwarcz, 1985, Dopamine agonist induced self-mutilative biting behavior in monkeys with unilateral ventromedial tegmental lesions of the brain stem: Possible pharmacological model for Lesch-Nyhan syndrome, Brain Res., in press.

    Google Scholar 

  8. R. Markstein, J.L. Jaton, J.M. Vigouret, R. Giger, A. Closse, U. Briner and, A. Enz, 1984, Pharmacological properties of 201–678 a new dopamine agonist, Clin. Neuropharmacol., 7:800–801.

    Article  Google Scholar 

  9. K.G. Lloyd, O. Hornykiewicz, L. Davidson, K. Shannak, I. Farley, M. Goldstein, M. Shibuya, W.N. Kelly and I.H. Fox, 1981, Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome, New Engl. J. Med., 305:1106–1111.

    Google Scholar 

  10. G. Kapatos, S. Katoh and S G. Kapatos, S. Katoh and S. Kaufman, Biosynthesis of biopterin by rat brain, 1982, J. Neurochem., 39:1152–1162.

    Article  PubMed  CAS  Google Scholar 

  11. R.J. Lefkowitz, M.C. Caron and G.L. Stiles, 1984, Mechanisms of membrane-receptor regulation: Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors, New Engl. J. Med., 310:1570–1579.

    Google Scholar 

  12. D.R. Howlett and S.R. Nahorski, 1980, Quantitative assessment of heterogeneous 3H-spiperone binding to rat neostriatum and frontal cortex, Life Sci., 26:511–517.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Plenum Press, New York

About this chapter

Cite this chapter

Goldstein, M., Kuga, S., Shimizu, Y., Meller, E. (1986). The Pathophysiological Functions Mediated by D1 Dopamine Receptors. In: Breese, G.R., Creese, I. (eds) Neurobiology of Central D1-Dopamine Receptors. Advances in Experimental Medicine and Biology, vol 204. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5191-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5191-7_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5193-1

  • Online ISBN: 978-1-4684-5191-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics